The Treat and Reduce Obesity Act of 2021 expands Medicare coverage for obesity treatment by allowing more healthcare providers, beyond just primary care physicians, to offer intensive behavioral therapy. It also enables Medicare to cover prescription drugs that help with weight loss for overweight individuals.
The Treat and Reduce Obesity Act of 2021 is a significant step forward in addressing obesity in the U.S. by broadening access to necessary behavioral therapy and medications, potentially leading to improved health outcomes for millions of Americans struggling with weight management.
Critics of the Treat and Reduce Obesity Act of 2021 argue that expanding Medicare coverage for obesity treatment may lead to increased healthcare costs and raise questions about the effectiveness of such interventions, as obesity is a complex issue influenced by various factors beyond medical treatment.
All donations are from individuals employed by Applied Materials, Inc., which is not directly related to the healthcare or obesity sectors. Therefore, the conflict-of-interest risk is low.
